The Efficacy of Aflibercept in the Management of Treatment-Resistant Diabetic Macular Oedema

被引：0
|
作者：
Bahrami, Bobak [1 ]
Ewe, Shaun [1 ]
Hong, Thomas [1 ]
Zhu, Meidong [1 ,2 ]
Peto, Tunde [3 ]
Levente, Toth [3 ]
Wong, James [1 ,2 ]
Chang, Andrew [1 ,2 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
[3] Moorfields Eye Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2015年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] Aflibercept is better drug for diabetic macular oedema, study finds
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [22] The efficacy and safety of intravitreal bevacizumab in the treatment of diabetic macular oedema
    Malysko, K.
    Kuoliene, K.
    Cimbalas, A.
    Asoklis, R.
    ACTA OPHTHALMOLOGICA, 2014, 92
  • [23] Diabetic macular oedema and diabetic retinopathy: treatment outcomes with aflibercept do not depend on systemic diabetes control
    Metzig, C.
    DIABETOLOGIA, 2014, 57 : S29 - S29
  • [24] Suprachoroidal injection of triamcinolone acetonide for management of resistant diabetic macular oedema
    Ateeq, Asim
    Majid, Saima
    Memon, Nasir Ahmed
    Hayat, Nausheen
    Somroo, Abdul Qadeem
    Fattah, Abdul
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (02) : 239 - 244
  • [25] Aflibercept for the treatment of diabetic macular edema
    Harkins, Keegan A.
    Haschke, Mary
    Do, Diana V.
    IMMUNOTHERAPY, 2016, 8 (05) : 503 - 510
  • [26] Diabetic macular oedema: pathophysiology, management challenges and treatment resistance
    Bahrami, Bobak
    Zhu, Meidong
    Hong, Thomas
    Chang, Andrew
    DIABETOLOGIA, 2016, 59 (08) : 1594 - 1608
  • [27] Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
    Chew, Emily Y.
    LANCET, 2024, 403 (10432): : 1111 - 1113
  • [28] Effect of intravitreal aflibercept treatment on retinal vessel parameters in diabetic macular oedema: Arteriolar vasoconstriction
    Sabaner, Mehmet Cem
    Dogan, Mustafa
    Duman, Resat
    CUTANEOUS AND OCULAR TOXICOLOGY, 2019, 38 (03) : 267 - 273
  • [29] Diabetic macular oedema: pathophysiology, management challenges and treatment resistance
    Bobak Bahrami
    Meidong Zhu
    Thomas Hong
    Andrew Chang
    Diabetologia, 2016, 59 : 1594 - 1608
  • [30] Intravitreal methotrexate in resistant diabetic macular oedema
    Naderipour, Mehdi
    Razzaghpour, Nayyereh
    Foumani, Mohammadrasoul Sabourinejad
    Najafi, Amin
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 1024 - 1024
12345